Advanced search
Publication Cover
Cell Cycle Volume 14, 2015 - Issue 13
Submit an article Journal homepage
2,474
Views
34
CrossRef citations to date
0
Altmetric
Reports

Fibroblast growth factor family aberrations in cancers: clinical and molecular characteristics

A ParishCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA
,
M SchwaederleCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA
,
G DanielsCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USA
,
D PiccioniCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USA
,
P FantaCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USA
,
R SchwabCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USA
,
K ShimabukuroCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USA
,
BA ParkerCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USA
,
T HelstenCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USA
&
R KurzrockCenter for Personalized Cancer Therapy; University of California San Diego; Moores Cancer Center; San Diego, CA, USA;Division of Hematology and Oncology; University of California San Diego; San Diego, CA, USACorrespondence[email protected]
 show all
Pages 2121-2128 | Received 18 Feb 2015, Accepted 11 Apr 2015, Published online: 13 Jun 2015

Citations (34)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Massimiliano Salati, Francesco Caputo, Cinzia Baldessari, Pietro Carotenuto, Marco Messina, Stefania Caramaschi, Massimo Dominici & Luca Reggiani Bonetti. (2021) The Evolving Role of FGFR2 Inhibitors in Intrahepatic Cholangiocarcinoma: From Molecular Biology to Clinical Targeting. Cancer Management and Research 13, pages 7747-7757.
Read now
Mrinal M. Patnaik, Rhett P. Ketterling & Ayalew Tefferi. (2018) FGFR1 rearranged hematological neoplasms – molecularly defined and clinically heterogeneous. Leukemia & Lymphoma 59:7, pages 1520-1522.
Read now
Antonella De Luca, Daniela Frezzetti, Marianna Gallo & Nicola Normanno. (2017) FGFR-targeted therapeutics for the treatment of breast cancer. Expert Opinion on Investigational Drugs 26:3, pages 303-311.
Read now

Articles from other publishers (31)

Carmel Hutchings & Dalit Sela-Donenfeld. (2023) Primer on FGF3. Differentiation, pages 100730.
Crossref
Alessio Ardizzone, Valentina Bova, Giovanna Casili, Alberto Repici, Marika Lanza, Raffaella Giuffrida, Cristina Colarossi, Marzia Mare, Salvatore Cuzzocrea, Emanuela Esposito & Irene Paterniti. (2023) Role of Basic Fibroblast Growth Factor in Cancer: Biological Activity, Targeted Therapies, and Prognostic Value. Cells 12:7, pages 1002.
Crossref
Michele Fiore, Alberto Taddia, Valentina Indio, Salvatore Nicola Bertuccio, Daria Messelodi, Salvatore Serravalle, Jessica Bandini, Filippo Spreafico, Daniela Perotti, Paola Collini, Andrea Di Cataldo, Gianandrea Pasquinelli, Francesca Chiarini, Maura Fois, Fraia Melchionda, Andrea Pession & Annalisa Astolfi. (2023) Molecular Signature of Biological Aggressiveness in Clear Cell Sarcoma of the Kidney (CCSK). International Journal of Molecular Sciences 24:4, pages 3743.
Crossref
Yishan Li, Lianru Zhang, Huiping Yu, Xiaoyan Xin, Jian He, Yongzhong Yao, Baorui Liu, Rutian Li & Li Xie. (2022) Case Report: Small intestinal metastatic breast cancer: A case report and literature review. Frontiers in Oncology 12.
Crossref
Schwartze JT, Havenga M, Bakker WAM, Bradshaw AC & Nicklin SA. (2022) Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective. Journal of Molecular Medicine 100:6, pages 875-901.
Crossref
Yichen Wang & Yoon-Young Jang. 2022. iPSCs - State of the Science. iPSCs - State of the Science 95 109 .
Syeda Kiran Riaz, Walizeb Khan, Fen Wang, Tanwir Khaliq, Amber Malik, Eisha Tir Razia, Jahangir Sarwar Khan, Shafiul Haque, Anwar M. Hashem, Shadi S. Alkhayyat, Najiah Esam Azhar, Steve Harakeh, Mohammad Javed Ansari, Farhan Haq & Muhammad Faraz Arshad Malik. (2021) Targeted Inhibition of Fibroblast Growth Factor Receptor 1-GLI Through AZD4547 and GANT61 Modulates Breast Cancer Progression. Frontiers in Cell and Developmental Biology 9.
Crossref
Yunhe Ju, Xingrao Wu, Huizhen Wang, Bin Li, Qing Long, Dadong Zhang, Hao Chen, Nianqing Xiao, Fugen Li, Shiwen Zhang & Shenggang Yang. (2021) Genomic Landscape of Head and Neck Squamous Cell Carcinoma Across Different Anatomic Sites in Chinese Population. Frontiers in Genetics 12.
Crossref
Giovanni Vitale, Alessia Cozzolino, Pasqualino Malandrino, Roberto Minotta, Giulia Puliani, Davide Saronni, Antongiulio Faggiano & Annamaria Colao. (2021) Role of FGF System in Neuroendocrine Neoplasms: Potential Therapeutic Applications. Frontiers in Endocrinology 12.
Crossref
Zhijian Jin, Haoran Feng, Juyong Liang, Xiaoqian Jing, Qiwu Zhao, Ling Zhan, Baiyong Shen, Xi Cheng, Liping Su & Weihua Qiu. (2020) FGFR3△7–9 promotes tumor progression via the phosphorylation and destabilization of ten-eleven translocation-2 in human hepatocellular carcinoma. Cell Death & Disease 11:10.
Crossref
Maria Francesca Santolla & Marcello Maggiolini. (2020) The FGF/FGFR System in Breast Cancer: Oncogenic Features and Therapeutic Perspectives. Cancers 12:10, pages 3029.
Crossref
Junyan Tao, Dantong Sun & Helei Hou. (2020) Role of YES1 amplification in EGFR mutation‐positive non‐small cell lung cancer: Primary resistance to afatinib in a patient . Thoracic Cancer 11:9, pages 2736-2739.
Crossref
Kevin Batcher, Peter Dickinson, Kimberly Maciejczyk, Kristin Brzeski, Sheida Hadji Rasouliha, Anna Letko, Cord Drögemüller, Tosso Leeb & Danika Bannasch. (2020) Multiple FGF4 Retrocopies Recently Derived within Canids. Genes 11:8, pages 839.
Crossref
Debbie L. Cunningham, Adil R. Sarhan, Andrew J. Creese, Katherine P. B. Larkins, Hongyan Zhao, Harriet R. Ferguson, Katie Brookes, Anna A. Marusiak, Helen J. Cooper & John K. Heath. (2020) Differential responses to kinase inhibition in FGFR2-addicted triple negative breast cancer cells: a quantitative phosphoproteomics study. Scientific Reports 10:1.
Crossref
Omar Elakad, Anna‐Maria Lois, Katja Schmitz, Sha Yao, Sara Hugo, Laura Lukat, Marc Hinterthaner, Bernhard C. Danner, Alexander Hammerstein‐Equord, Kirsten Reuter‐Jessen, Hans‐Ulrich Schildhaus, Philipp Ströbel & Hanibal Bohnenberger. (2020) Fibroblast growth factor receptor 1 gene amplification and protein expression in human lung cancer. Cancer Medicine 9:10, pages 3574-3583.
Crossref
Peng Wei, Bo Liu, Ruifeng Wang, Yinglei Gao, Lanlan Li, Yuchi Ma, Zhiwei Qian, Yuelei Chen, Maosheng Cheng, Meiyu Geng, Jingkang Shen, Dongmei Zhao, Jing Ai & Bing Xiong. (2019) Discovery of a series of dimethoxybenzene FGFR inhibitors with 5H-pyrrolo[2,3-b]pyrazine scaffold: structure–activity relationship, crystal structural characterization and in vivo study. Acta Pharmaceutica Sinica B 9:2, pages 351-368.
Crossref
Jian-Ri Li, Kun-Yuan Chiu, Yen-Chuan Ou, Shian-Shiang Wang, Chuan-Su Chen, Cheng-Kuang Yang, Hao-Chung Ho, Chen-Li Cheng, Chi-Rei Yang, Cheng-Che Chen, Shu-Chi Wang, Chia-Yen Lin, Sheng-Chun Hung, Chiann-Yi Hsu & Chun-Jung Chen. (2019) Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma. BioFactors 45:1, pages 62-68.
Crossref
J. E. Fromme & H.-U. Schildhaus. (2018) FGFR3-Überexpression ist eine relevante Alteration in kolorektalen KarzinomenFGFR3 overexpression is a relevant alteration in colorectal cancer. Der Pathologe 39:S2, pages 189-192.
Crossref
Ecaterina Ileana DumbravaRasha AlfattalVincent A. MillerApostolia Maria Tsimberidou. (2018) Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications . JCO Precision Oncology:2, pages 1-7.
Crossref
Julia Elisabeth Fromme, Katja Schmitz, Astrid Wachter, Marius Grzelinski, Dirk Zielinski, Christina Koppel, Lena-Christin Conradi, Kia Homayounfar, Tabea Hugo, Sara Hugo, Laura Lukat, Josef Rüschoff, Philipp Ströbel, Michael Ghadimi, Tim Beißbarth, Kirsten Reuter-Jessen, Annalen Bleckmann & Hans-Ulrich Schildhaus. (2018) FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis. Oncotarget 9:63, pages 32204-32218.
Crossref
Katarzyna Starska, Ewa Forma, Iwona Lewy-Trenda, Olga Stasikowska-Kanicka, Michał Skóra & Magdalena Bryś. (2018) Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer. Cellular Oncology 41:3, pages 253-268.
Crossref
Alan Jiang, Qiufeng Liu, Ruifeng Wang, Peng Wei, Yang Dai, Xin Wang, Yechun Xu, Yuchi Ma, Jing Ai, Jingkang Shen, Jian Ding & Bing Xiong. (2018) Structure-Based Discovery of a Series of 5H-Pyrrolo[2,3-b]pyrazine FGFR Kinase Inhibitors. Molecules 23:3, pages 698.
Crossref
Shuzo Tamura, Yin Wang, Brendan Veeneman, Daniel Hovelson, Armand Bankhead, Luke J. Broses, Guadalupe Lorenzatti Hiles, Monica Liebert, John R. Rubin, Kathleen C. Day, Maha Hussain, Nouri Neamati, Scott Tomlins, Philip L. Palmbos, Petros Grivas & Mark L. Day. (2018) Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer. Bladder Cancer 4:1, pages 77-90.
Crossref
Prasad R. Koduru, Kathleen Wilson, Jiadi Wen, Rolando Garcia, Sangeeta Patel & Sara A. Monaghan. (2017) Cytogenetic and Cytogenomic Microarray Characterization of Chromothripsis in Chromosome 8 Affecting MOZ/NCOA2 (TIF2), FGFR1, RUNX1T1, and RUNX1 in a Pediatric Acute Myeloid Leukemia. Journal of Pediatric Hematology/Oncology 39:4, pages e227-e232.
Crossref
Yan Zhang, Hongchun Liu, Zhen Zhang, Ruifeng Wang, Tongchao Liu, Chaoyun Wang, Yuchi Ma, Jing Ai, Dongmei Zhao, Jingkang Shen & Bing Xiong. (2017) Discovery and Biological Evaluation of a Series of Pyrrolo[2,3-b]pyrazines as Novel FGFR Inhibitors. Molecules 22:4, pages 583.
Crossref
Xiaopeng Yan, Cong Shao, Chuang Chen, Jun Chen, Shen Gu, Luoshun Huang, Xu Fu, Hui Zhao & Yudong Qiu. (2017) Mutation Detection of Fibroblast Growth Factor Receptor 3 for Infiltrative Hepatocellular Carcinoma by Whole-Exome Sequencing. Digestive Diseases and Sciences 62:2, pages 407-417.
Crossref
Luyao Chen, Zhengwei Lei, Xin Ma, Qingbo Huang, Xu Zhang, Yong Zhang, Peng Hao, Minggang Yang, Xuetao Zhao, Jun Chen, Gongxue Liu & Tao Zheng. (2016) Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population. Scientific Reports 6:1.
Crossref
Lisha Qi, Wangzhao Song, Lingmei Li, Lu Cao, Yue Yu, Chunmin Song, Yalei Wang, Fei Zhang, Yang Li, Bin Zhang & Wenfeng Cao. (2016) FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma. Oncotarget 7:45, pages 74015-74030.
Crossref
Thao Nguyen & René Marc Mège. (2016) N-Cadherin and Fibroblast Growth Factor Receptors crosstalk in the control of developmental and cancer cell migrations. European Journal of Cell Biology 95:11, pages 415-426.
Crossref
Ricardo Costa, Benedito A. Carneiro, Timothy Taxter, Fabio A. Tavora, Aparna Kalyan, Sachin A. Pai, Young Kwang Chae & Francis J. Giles. (2016) FGFR3-TACC3 fusion in solid tumors: mini review . Oncotarget 7:34, pages 55924-55938.
Crossref
Shumei Kato, Scott M. Lippman, Keith T. Flaherty & Razelle Kurzrock. (2016) The Conundrum of Genetic “Drivers” in Benign Conditions. Journal of the National Cancer Institute 108:8, pages djw036.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.